The Food and Drug Administration (FDA) has approved both drugs for weight management in adults with: a body mass index (BMI) of 30 or higher (obesity) a BMI of 27 or higher (overweight) plus at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol Wegovy also has the following approved uses: Cardiovascular health: Wegovy is approved to reduce the risk of major heart-related events like heart attack or stroke in adults with known heart disease who have obesity or are overweight
It can be seamlessly integrated with other treatments and therapies to enhance their effectiveness
They found that adult serotonin deficiency led to a unique combination of hyperactivity, disrupted circadian behavior patterns, and the absence of siestas (a period of increased sleep during the active phase)
They may seem to arise suddenly and have no direct or immediate cause
She broke the news on her talk show
[1] The most frequently reported adverse effects of semaglutide include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, constipation, and abdominal pain